When psoriasis manifests in palmoplantar and intertriginous regions or on the nails, this often poses a therapeutic challenge. Several recently presented analyses on the effects of anti-IL-23p19 antibodies currently approved for psoriasis focused on patient populations with infestation of these difficult-to-treat body regions.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Clinically Suspected Arthralgias
“Watchful waiting” or intervention?
- Tumors of the Calcaneus
Diagnostic Challenges of Rare Heel Tumors
- Upper GI Tract Bleeding: Hematemesis, Hematochezia, or Melena?
From Risk Stratification to Post-Endoscopic Management
- Obesity, Nutrition, and Mental Health
Depression, Binge Eating, Internalized Stigma
- From Hypertension to Heart Failure?
When and how to intervene
- Switzerland's First PTH Replacement Therapy
Palopegteriparatide for Chronic Hypoparathyroidism
- Case study
Orofacial Manifestations of Phelan-McDermid Syndrome
- Quitting smoking reduces cardiovascular risks